CSIR touts dubious 'Ayurveda' product for diabetes
At 6 am on September 13, the CSIR handle on X.com published the following post about an "anti-diabetic medicine" called either "Daiba 250" or "Diabe 250", developed at th…
3 posts
At 6 am on September 13, the CSIR handle on X.com published the following post about an "anti-diabetic medicine" called either "Daiba 250" or "Diabe 250", developed at th…
The Surya Tilak project had courted controversy in the past with Trinamool Congress's Mahua Moitra flagging it on social media in November 2021. The CSIR officials, however, defended the project a…
K. VijayRaghavan, India’s new principal scientific advisor to the Government of India, has brought a lot of hope with him into the role as a result of his illustrious career as a biologist and former…